Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Project Oncology®

Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Our understanding of high-risk multiple myeloma has greatly evolved over the past 15 to 20 years, yielding new insights into its classification, genetic factors that play a role in its development and progression, and advanced treatment approaches. Learn more with Dr. Gareth Morgan, Director of Multiple Myeloma Research at NYU Langone’s Perlmutter Cancer Center.

Recommended
Details
Presenters
Comments
  • Overview

    Our understanding of high-risk multiple myeloma has greatly evolved over the past 15 to 20 years, yielding new insights into its classification, genetic factors that play a role in its development and progression, and advanced treatment approaches. Learn more with Dr. Gareth Morgan, Director of Multiple Myeloma Research at NYU Langone’s Perlmutter Cancer Center.

Schedule14 Oct 2024